ForteBio
Latest round
- Series C
Last raised
- Sep 2008
Total raised
- $42M
Investors
- 7
About ForteBio
ForteBio is based in the US and operates as a life science company which develops analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences.
Who invested in ForteBio
7 investors across 3 rounds
See all investors in ForteBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ForteBio
Who invested in ForteBio?
ForteBio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ForteBio raised?
ForteBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ForteBio last raise money?
ForteBio's most recent round on record is a Series C, in Sep 2008.
What does ForteBio do?
ForteBio is based in the US and operates as a life science company which develops analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction.
Where is ForteBio headquartered?
ForteBio is headquartered in Menlo Park, US.
Which VCs invest in companies like ForteBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ForteBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ForteBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.